Search

Promoting growth

Long-term partner for start-ups

We have already accompanied over 100 start-up projects. We usually acquire a minority share in the resulting companies.

We continue to support our portfolio companies on their growth trajectory and manage our shares as profitably as possible until exit – or, in the case of floatation or takeovers by listed companies, beyond.

We distribute most of our revenues from the sale of equity and shares to the LifeScience Foundation, which in turn makes them available to its endowing institutes as research grants

Current shareholdings

[Translate to English:]

AI-powered precision diagnostics for pathology

Genetic organ modification for solving the problem of organ rejection

Development of innovative therapies that target regulatory autoantibody-associated diseases

 

AI-supported analysis software for proteomics mass spectrometry data

Sovereign AI for hospitals

Further development of the antitumor chemotherapeutic agent bendamustine

Research and experimental development on medical science

 

Convertion of carbon-containing mixtures of substances from industrial waste streams into new products with the help of a yeast-like fungus

 

[Translate to English:]

RNA hair test for your body clock: Identify your sleeping type & reasons for sleeping problems - Fall asleep better and sleep through the night 

[Translate to English:]

T-cell immunotherapy for untreatable blood cancer patients

CAR T-cell immunotherapies for the treatment of blood cancer and autoimmune diseases

 

AI-powered precision oncology platform

[Translate to English:]

Next level for molecular diagnostics in human skin to improve patients‘ lives and clinical practice in dermatology

[Translate to English:]

No-code platform for medical workflows

Therapy / Novel vaccines against the Epstein-Barr virus

[Translate to English:]

Discovery and development of new chemical entities for treatment of acute and chronic liver diseases

[Translate to English:]

Novel cell screening technologies for drug development

[Translate to English:]

Qualitative and quantitative measurement of the biological decomposition of toxic waste (contaminated soil)

Innovative stabilisation of cell samples for more accurate diagnostics

 

Development of a fully automated tissue preserving 3D histopathology platform for clinical use

Mining of previously undiscovered parts of human DNA to revolutionize healthcare through AI-powered solutions

[Translate to English:]

Advisory service for the application of hyperthermia therapy

Development of an alternative to cortisone with few side effects

[Translate to English:]

Platform to digitize healthcare for all poor countries

Preclinical contract research organization offering drug discovery services with an exceptional compound library

[Translate to English:]

Easy-to-use early detection tool for Acute Kidney Injury (AKI)

 

[Translate to English:]

Development of small molecules using an innovative endogenous protective mechanism. Primary focus is the development of a first-in-class oral drug for…

[Translate to English:]

Photoionization mass spectrometry for the direct analysis of complex organic gasses and solids

[Translate to English:]

Diagnosing cortical bone health with ultrasound

Development of ATMPs based on recombinase driven error-free genome editing for eradication of life-threatening virus infection

Innovative solutions for remote monitoring of people with rare and neurological diseases

Development of disruptive non-invasive technologies to measure blood metabolites in humans

[Translate to English:]

Development of T cell receptors (TCRs) for T cell therapy of cancer 

[Translate to English:]

Modular technology platform for generating and applying innovative regulatory T cell products for various immune diseases.

Saliva test to determine the optimal time for chemotherapy

[Translate to English:]

Novel TPH1 inhibitors for serotonin-dependent diseases

Early detection system for dementia

Therapy for EBV-associated tumors

Development of siRNA inhalation drugs for severe lung disease

Former shareholdings

    • Activaero GmbH

    • Alerion

    • amcure GmbH

    • Berlin Cures

    • BigChem GmbH

    • Biomax AG

    • Bioregeneration GmbH

    • BITZ GmbH

    • Canopy Biosciences

    • Cardior Pharmaceuticals

    • CERNT GmbH

    • Consentris GmbH

    • Clueda AG

    • CoImmune

    • DentalXrai

    • eADMET GmbH

    • Encepharm GmbH

    • Genomatix GmbH

    • Inamed GmbH

    • iThera Medical GmbH

    • Klaria Pharma

    • Leopard Biosciences

    • Medigene AG

    • Recovery Cat

    • NanoRepro AG

    • RadioEye GmbH

    • Roscue Therapeutics GmbH

    • Spero Therapeutics LLC

    • SurgVision B.V.

    • Trianta Immunotherapies GmbH

    • TRION Pharma GmbH

    • Tube Pharmaceutical GmbH

    • Vakzine Projekt Management GmbH

    • Vectura Group plc

    • WBC Drug Delivery Technologies

    • Zellkraftwerk GmbH

    • Activaero GmbH

    • Bioregeneration GmbH

    • BITZ GmbH

    • Clueda AG

    • eADMET GmbH

    • Encepharm GmbH

    • Genomatix GmbH

    • Inamed GmbH

    • SurgVision B.V.

    • Trianta Immunotherapies GmbH

    • TRION Pharma GmbH

    • Vakzine Projekt Management GmbH

    • WBC Drug Delivery Technologies

    • Zellkraftwerk GmbH

    • amcure GmbH

    • DentalXrai

    • Vectura Group plc

    • Berlin Cures

    • Cardior Pharmaceuticals

    • CERNT GmbH

    • Klaria Pharma

    • Consentris GmbH

    • Tube Pharmaceutical GmbH

    • WBC Drug Delivery Technologies

    • CoImmune